Research Products

Respiratory Infectious Diseases

Prodesse ProParaflu+ Assay

An easy-to-use real-time multiplex RT-PCR kit for detection and differentiation of

  • Parainfluenza 1
  • Parainfluenza 2
  • Parainfluenza 3

The parainfluenza viruses are second only to RSV in causing lower respiratory disease in children. Parainfluenza 1 is the leading cause of croup. ProParaflu+ offers laboratories, clinicians and their patients an important tool for the diagnosis and differentiation of viral respiratory disease.

Results in as little as 4 hours
Like all of Prodesse's products, the ProParaflu+ assay uses proven real-time PCR technology, ensuring that accurate test results are delivered quickly and easily. The test's compatibility with automated nucleic-acid extraction technology minimizes hands-on time and expedites results. All the reagents you need, except water, are included in the kit.

Easy to use and implement in the lab
Designed to run on standard molecular diagnostic equipment, the ProParaflu+ assay has a simple workflow that makes it easy to implement and validate. A common RNA Internal Control allows a single nucleic-acid extract to be used in any combination of Prodesse's respiratory RNA virus Assays.

DescriptionQuantityCatalog
ProParaflu+ Assay Kit
Detects: Parainfluenza 1, 2, 3. (Supermix [with taq], MMLV, RNase Inhibitor and Internal and Positive Control)
100 reactions H81VK00
Cat #ProductKit SizePI
H81VK00 ProParaflu+ Detection Kit 100 PI
Cat #ProductKit SizeMSDS
H81VK00 ProParaflu+ Detection Kit 100 HSM81 HCT81 GCT12 GLS32 GLS33

The ProParaflu+ assay was cleared for In Vitro Diagnostic Use by the FDA in 2009.

For additional availability in other countries please contact your local sales rep or distributor.

Propara Flu Performance Data

Discrepant analysis (genetic sequencing):
1 PCR positive, culture negative specimen:

  • 1 sample positive by sequence analysis

2 PCR negative, culture positive specimens:

  • 2 samples negative by sequence analysis
  • 1 positive for parainfluenza 3 by ProParaflu+ and by sequence analysis

 

Proparaflu Performance Data

Discrepant analysis (genetic sequencing):
2 PCR positive, culture negative specimens:

  • 2 samples positive by sequence analysis

1 PCR negative, culture positive specimen:

  • 1 sample negative by sequence analysis

 

Proparaflu Performance Data

Discrepant analysis (genetic sequencing):

8 PCR positive, culture negative specimens:

  • 7 samples positive by sequence analysis
  • 1 sample negative by sequence analysis

1 PCR negative, culture positive specimen:

  • 1 sample negative by sequence analysis

Please see package insert for detailed information.